Angelos Dovletoglou

Angelos Dovletoglou has extensive experience in the biotechnology and pharmaceutical industries. Angelos is currently working as the Senior Vice President of Technical Operations at Repare Therapeutics since 2021. Prior to that, they held the same position at Origin Biosciences from 2018 to 2021, where they played a key role in developing a treatment for molybdenum cofactor deficiency. Angelos was also involved in regulatory affairs and preclinical development at Epizyme from 2011 to 2018, where they achieved significant milestones in various functions. In addition, Angelos Dovletoglou has held leadership positions at MassBio, Cocoon Biotech, Biogen, Momenta Pharma, and Merck Research Laboratories, where they contributed to the development and commercialization of various pharmaceutical products. Angelos Dovletoglou has also been involved in industry organizations, serving on the DCAT Education Committee and holding various roles at MassBio and the Product Quality Research Institute.

Angelos Dovletoglou pursued their education in the field of chemistry, focusing on organometallic chemistry. Angelos first attended the Ethnikon kai Kapodistriakon Panepistimion Athinon from 1984 to 1988, where they obtained a Bachelor of Science degree. Later, they enrolled at the University of North Carolina at Chapel Hill, where they pursued a Ph.D. in Inorganic Chemistry from 1988 to 1992.